A thousand reference genomes of the highest quality have now been produced for diverse eukaryotic species across the tree of life.
The Sanger Institute is committed to innovative science at scale, but we need partners and investors to transfer this science into the clinic. Mariya Chhatriwala, Business Development Manager, gives us her insights on how the Sanger Institute’s fifth spin-out company came to be.
Histologists, cardiologists, immunologists, cell biologists, software developers, bioinformaticians and specialist technicians have worked together to see individual cells in unprecedented detail. Using spatial genomics, they located each cell to its precise location in the heart.
Chenqu Suo looks back on her PhD, discussing her scientific highlights and her thoughts about what makes the Sanger Institute a special place to study.
The Sanger Institute’s new Respiratory Virus and Microbiome Initiative will lead the way in developing the genomic tools and methodology to study and track a range of viruses and understand how they interact with the respiratory microbiome and human hosts.
Ian Dunham has been a pillar of Open Targets since its inception. Helena Cornu sat down with him to understand how his career led him from the Human Genome Project to Director of Open Targets, and what he envisions for the future of the consortium.